Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/23497
標題: Stenotrophomonas maltophilia MopB 外膜蛋白之分析
Characteristics of MopB protein in Stenotrophomonas maltophilia
作者: 吳漢強
Wu, Han-Chiang
關鍵字: Stenotrophomonas maltophilia;非醱酵性的嗜氧革蘭氏陰性桿菌;outer membrane protein (Omp);MopB;外膜蛋白
出版社: 生命科學院碩士在職專班
引用: Reference List Aisenberg,G., Rolston,K.V., Dickey,B.F., Kontoyiannis,D.P., Raad,I.I., and Safdar,A. (2007) Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. Eur J Clin Microbiol Infect Dis 26: 13-20. Alonso,A., and Martinez,J.L. (1997) Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 41: 1140-1142. Alonso,A., and Martinez,J.L. (2000) Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 44: 3079-3086. Ballestero,S., Virseda,I., Escobar,H., Suarez,L., and Baquero,F. (1995) Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 14: 728-729. Bardy,S.L., Ng,S.Y., and Jarrell,K.F. (2003) Prokaryotic motility structures. Microbiology 149: 295-304. Bauer,A.W., Kirby,W.M., Sherris,J.C., and Turck,M. (1966) Antibiotic susceptibility testing by a standardized single disk method. Tech Bull Regist Med Technol 36: 49-52. Bond,P.J., Faraldo-Gomez,J.D., and Sansom,M.S. (2002) OmpA: a pore or not a pore? Simulation and modeling studies. Biophys J 83: 763-775. Burns,J.L., Emerson,J., Stapp,J.R., Yim,D.L., Krzewinski,J., Louden,L. et al. (1998) Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 27: 158-163. Chen,Y.Y., Wu,C.H., Lin,J.W., Weng,S.F., and Tseng,Y.H. (2010) Mutation of the gene encoding a major outer membrane protein in Xanthomonas campestris pv. campestris causes pleiotropic effects including loss of pathogenicity. Microbiology. Chevalier,J., Pages,J.M., Eyraud,A., and Mallea,M. (2000) Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae. Biochem Biophys Res Commun 274: 496-499. Crossman,L.C., Gould,V.C., Dow,J.M., Vernikos,G.S., Okazaki,A., Sebaihia,M. et al. (2008) The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9: R74. Cullmann,W. (1991) Antibiotic susceptibility and outer membrane proteins of clinical Xanthomonas maltophilia isolates. Chemotherapy 37: 246-250. de Oliveira-Garcia,D., Dall''Agnol,M., Rosales,M., Azzuz,A.C., Alcantara,N., Martinez,M.B., and Giron,J.A. (2003) Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol 5: 625-636. de Oliveira-Garcia,D., Dall''Agnol,M., Rosales,M., Azzuz,A.C., Martinez,M.B., and Giron,J.A. (2002) Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia. Emerg Infect Dis 8: 918-923. del Toro,M.D., Rodriguez-Bano,J., Martinez-Martinez,L., Pascual,A., Perez-Canoa,R., Perea,E.J., and Muniain,M.A. (2006) [Epidemiology, clinical features and prognosis of infections due to Stenotrophomonas maltophilia]. Enferm Infecc Microbiol Clin 24: 4-9. Denton,M., and Kerr,K.G. (1998) Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11: 57-80. Di,B.G., Prosseda,G., Del,C.F., Cannavacciuolo,S., Cipriani,P., Petrucca,A. et al. (2007) Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int J Immunopathol Pharmacol 20: 529-537. Dunne,W.M., Jr. (2002) Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev 15: 155-166. Eaton,K.A., Suerbaum,S., Josenhans,C., and Krakowka,S. (1996a) Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect Immun 64: 2445-2448. Eaton,K.A., Suerbaum,S., Josenhans,C., and Krakowka,S. (1996b) Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect Immun 64: 2445-2448. Elting,L.S., and Bodey,G.P. (1990) Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 69: 296-306. Figueiredo,P.M., Furumura,M.T., Santos,A.M., Sousa,A.C., Kota,D.J., Levy,C.E., and Yano,T. (2006) Cytotoxic activity of clinical Stenotrophomonas maltophilia. Lett Appl Microbiol 43: 443-449. Fjellbirkeland,A., Bemanian,V., McDonald,I.R., Murrell,J.C., and Jensen,H.B. (2000) Molecular analysis of an outer membrane protein, MopB, of Methylococcus capsulatus (Bath) and structural comparisons with proteins of the OmpA family. Arch Microbiol 173: 346-351. Frank,S.K., and Gerber,J.D. (1981) Hydrolytic enzymes of Moraxella bovis. J Clin Microbiol 13: 269-271. Franzetti,F., Cernuschi,M., Esposito,R., and Moroni,M. (1992) Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med 231: 437-443. Fritsche,T.R., Sader,H.S., Stilwell,M.G., Dowzicky,M.J., and Jones,R.N. (2005) Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Diagn Microbiol Infect Dis 52: 187-193. Gales,A.C., Jones,R.N., Andrade,S.S., and Sader,H.S. (2005) Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). Mem Inst Oswaldo Cruz 100: 571-577. Gales,A.C., Jones,R.N., Forward,K.R., Linares,J., Sader,H.S., and Verhoef,J. (2001) Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 32 Suppl 2: S104-S113. Gopalakrishnan,R., Hawley,H.B., Czachor,J.S., Markert,R.J., and Bernstein,J.M. (1999) Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: A study of 143 patients. Heart Lung 28: 134-141. Gottenbos,B., van der Mei,H.C., and Busscher,H.J. (1999) Models for studying initial adhesion and surface growth in biofilm formation on surfaces. Methods Enzymol 310: 523-534. Henning,U., Sonntag,I., and Hindennach,I. (1978) Mutants (ompA) affecting a major outer membrane protein of Escherichia coli K12. Eur J Biochem 92: 491-498. Hogan,D., and Kolter,R. (2002) Why are bacteria refractory to antimicrobials? Curr Opin Microbiol 5: 472-477. Hugh,R. (1981) Pseudomonas-Maltophilia Sp-Nov Nom-Rev. International Journal of Systematic Bacteriology 31: 195. HUGH,R., and RYSCHENKOW,E. (1961) Pseudomonas maltophilia, an alcaligenes-like species. J Gen Microbiol 26: 123-132. Jones,R.N., Sader,H.S., and Beach,M.L. (2003) Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). Int J Antimicrob Agents 22: 551-556. Kerr,K.G., Corps,C.M., and Hawkey,P.M. (1991) Infections due to Xanthomonas maltophilia in patients with hematologic malignancy. Rev Infect Dis 13: 762. Khardori,N., Elting,L., Wong,E., Schable,B., and Bodey,G.P. (1990) Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 12: 997-1003. Kleinschmidt,J.H., and Tamm,L.K. (2002) Structural transitions in short-chain lipid assemblies studied by (31)P-NMR spectroscopy. Biophys J 83: 994-1003. Koebnik,R., Locher,K.P., and Van,G.P. (2000) Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol Microbiol 37: 239-253. Krogfelt,K.A. (1991) Bacterial adhesion: genetics, biogenesis, and role in pathogenesis of fimbrial adhesins of Escherichia coli. Rev Infect Dis 13: 721-735. Krueger,T.S., Clark,E.A., and Nix,D.E. (2001) In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations. Diagn Microbiol Infect Dis 41: 71-78. Lai,C.H., Chi,C.Y., Chen,H.P., Chen,T.L., Lai,C.J., Fung,C.P. et al. (2004) Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 37: 350-358. Lambert,T., Ploy,M.C., Denis,F., and Courvalin,P. (1999) Characterization of the chromosomal aac(6'')-Iz gene of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 43: 2366-2371. Li,X.Z., Zhang,L., McKay,G.A., and Poole,K. (2003) Role of the acetyltransferase AAC(6'')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. J Antimicrob Chemother 51: 803-811. Liu,P.V., and Shokrani,F. (1978) Biological activities of pyochelins: iron-chelating agents of Pseudomonas aeruginosa. Infect Immun 22: 878-890. Lockhart,S.R., Abramson,M.A., Beekmann,S.E., Gallagher,G., Riedel,S., Diekema,D.J. et al. (2007) Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 45: 3352-3359. Looney,W.J. (2005) Role of Stenotrophomonas maltophilia in hospital-acquired infection. Br J Biomed Sci 62: 145-154. Mahenthiralingam,E., and Speert,D.P. (1995) Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum. Infect Immun 63: 4519-4523. Martinez,J.L., Baquero,F., and Andersson,D.I. (2007) Predicting antibiotic resistance. Nat Rev Microbiol 5: 958-965. Merritt,E.A., and Hol,W.G. (1995) AB5 toxins. Curr Opin Struct Biol 5: 165-171. Mett,H., Rosta,S., Schacher,B., and Frei,R. (1988) Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. Rev Infect Dis 10: 765-769. Micozzi,A., Venditti,M., Monaco,M., Friedrich,A., Taglietti,F., Santilli,S., and Martino,P. (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31: 705-711. Mietzner,T.A., and Morse,S.A. (1994) The role of iron-binding proteins in the survival of pathogenic bacteria. Annu Rev Nutr 14: 471-493. Morona,R., Kramer,C., and Henning,U. (1985) Bacteriophage receptor area of outer membrane protein OmpA of Escherichia coli K-12. J Bacteriol 164: 539-543. Morrison,A.J., Jr., Hoffmann,K.K., and Wenzel,R.P. (1986) Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol 24: 52-55. Muder,R.R., Harris,A.P., Muller,S., Edmond,M., Chow,J.W., Papadakis,K. et al. (1996) Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis 22: 508-512. Nikaido,H., and Normark,S. (1987) Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment. Mol Microbiol 1: 29-36. Normark,B.H., and Normark,S. (2002) Evolution and spread of antibiotic resistance. J Intern Med 252: 91-106. O''Brien,M., and Davis,G.H. (1982) Enzymatic profile of Pseudomonas maltophilia. J Clin Microbiol 16: 417-421. Oliver,A., Alarcon,T., Caballero,E., and Canton,R. (2009) [Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis]. Enferm Infecc Microbiol Clin 27: 89-104. Paez,J.I., and Costa,S.F. (2008) Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect 70: 101-108. Palleroni,N.J., and Bradbury,J.F. (1993) Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Bacteriol 43: 606-609. Pizarro-Cerda,J., and Cossart,P. (2006) Bacterial adhesion and entry into host cells. Cell 124: 715-727. Pompilio,A., Catavitello,C., Picciani,C., Confalone,P., Piccolomini,R., Savini,V. et al. (2010) Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis. J Med Microbiol 59: 76-81. Pompilio,A., Piccolomini,R., Picciani,C., D''Antonio,D., Savini,V., and Di,B.G. (2008) Factors associated with adherence to and biofilm formation on polystyrene by Stenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. FEMS Microbiol Lett 287: 41-47. Ramphal,R., Arora,S.K., and Ritchings,B.W. (1996a) Recognition of mucin by the adhesin-flagellar system of Pseudomonas aeruginosa. Am J Respir Crit Care Med 154: S170-S174. Ramphal,R., Arora,S.K., and Ritchings,B.W. (1996b) Recognition of mucin by the adhesin-flagellar system of Pseudomonas aeruginosa. Am J Respir Crit Care Med 154: S170-S174. Ried,G., and Henning,U. (1987) A unique amino acid substitution in the outer membrane protein OmpA causes conjugation deficiency in Escherichia coli K-12. FEBS Lett 223: 387-390. Robertsson,J.A., Svenson,S.B., Renstrom,L.H., and Lindberg,A.A. (1982) Defined salmonella antigens for detection of cellular and humoral immune responses in salmonella infected calves. Res Vet Sci 33: 221-227. Rosenthal,S.L. (1974) Sources of pseudomonas and acinetobacter species found in human culture materials. Am J Clin Pathol 62: 807-811. Sader,H.S., and Jones,R.N. (2005) Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 25: 95-109. Sarkar,T.K., Gilardi,G., Aguam,A.S., Josephson,J., and Leventhal,G.L. (1979) Primary Pseudomonas maltophilia infection of the lung. Postgrad Med 65: 253-6, 260. Schaumann,R., Stein,K., Eckhardt,C., Ackermann,G., and Rodloff,A.C. (2001) Infections caused by Stenotrophomonas maltophilia--a prospective study. Infection 29: 205-208. Schiavo,G., Benfenati,F., Poulain,B., Rossetto,O., Polverino de,L.P., DasGupta,B.R., and Montecucco,C. (1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359: 832-835. Senol,E. (2004) Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen. J Hosp Infect 57: 1-7. Senol,E., DesJardin,J., Stark,P.C., Barefoot,L., and Snydman,D.R. (2002) Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 34: 1653-1656. Stathopoulos,C. (1996) An alternative topological model for Escherichia coli OmpA. Protein Science 5: 170-173. Steffen,E.K., and Hentges,D.J. (1981) Hydrolytic enzymes of anaerobic bacteria isolated from human infections. J Clin Microbiol 14: 153-156. Sugawara,E., Steiert,M., Rouhani,S., and Nikaido,H. (1996) Secondary structure of the outer membrane proteins OmpA of Escherichia coli and OprF of Pseudomonas aeruginosa. J Bacteriol 178: 6067-6069. Swings,J., Devos,P., Vandenmooter,M., and Deley,J. (1983) Transfer of Pseudomonas-Maltophilia Hugh 1981 to the Genus Xanthomonas As Xanthomonas-Maltophilia (Hugh 1981) Comb-Nov. International Journal of Systematic Bacteriology 33: 409-413. Tatman-Otkun,M., Gurcan,S., Ozer,B., Aydoslu,B., and Bukavaz,S. (2005) The antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness. BMC Microbiol 5: 24. Travassos,L.H., Pinheiro,M.N., Coelho,F.S., Sampaio,J.L., Merquior,V.L., and Marques,E.A. (2004) Phenotypic properties, drug susceptibility and genetic relatedness of Stenotrophomonas maltophilia clinical strains from seven hospitals in Rio de Janeiro, Brazil. J Appl Microbiol 96: 1143-1150. Tsiodras,S., Pittet,D., Carmeli,Y., Eliopoulos,G., Boucher,H., and Harbarth,S. (2000) Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. Scand J Infect Dis 32: 651-656. VanCouwenberghe,C.J., Farver,T.B., and Cohen,S.H. (1997) Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens. Infect Control Hosp Epidemiol 18: 316-321. Vartivarian,S., Anaissie,E., Bodey,G., Sprigg,H., and Rolston,K. (1994a) A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother 38: 624-627. Vartivarian,S.E., Papadakis,K.A., Palacios,J.A., Manning,J.T., Jr., and Anaissie,E.J. (1994b) Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum. Ann Intern Med 121: 969-973. Villarino,M.E., Stevens,L.E., Schable,B., Mayers,G., Miller,J.M., Burke,J.P., and Jarvis,W.R. (1992) Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. Infect Control Hosp Epidemiol 13: 201-206. Wang,W.S., Liu,C.P., Lee,C.M., and Huang,F.Y. (2004) Stenotrophomonas maltophilia bacteremia in adults: four years'' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 37: 359-365. Welch,R.A. (1991) Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol 5: 521-528. Wexler,H.M. (2002a) Outer-membrane pore-forming proteins in gram-negative anaerobic bacteria. Clinical Infectious Diseases 35: S65-S71. Wexler,H.M. (2002b) Outer-membrane pore-forming proteins in gram-negative anaerobic bacteria. Clin Infect Dis 35: S65-S71. Zgair,A.K., and Chhibber,S. (2010) Flagellin of Stenotrophomonas maltophilia induces compartmentalized innate immune response in mouse lung. J Med Microbiol. Zhang,L., Li,X.Z., and Poole,K. (2001a) SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 45: 3497-3503. Zhang,L., Li,X.Z., and Poole,K. (2001b) SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 45: 3497-3503.
摘要: 
非醱酵性的嗜氧革蘭氏陰性桿菌Stenotrophomonas maltophilia (S. maltophilia),普遍存在於自然環境中,如土壤、污水等。近年研究發現,癌症、免疫力缺失和長期使用抗生素等之病患的院內感染率持續提高,可能與此菌之感染有關。細菌之外膜蛋白 (outer membrane proteins, Omps)負責維持外膜的完整性,且擔任黏著素 (adhesins) 和運輸者 (transporter) 的角色,並與抗藥性 (antimicrobial resistance) 及致病性因子 (virulent factors) 的釋出有關。已知MopB為 S. maltophilia 最主要之外膜蛋白。為探討細菌感染動物細胞時此蛋白所扮演之角色,本實驗室曾經突變S. maltophilia ATCC13637 (Sm 13637)之 mopB基因,獲得突變株,命名為SmMopB。本研究中首先比較野生株Sm 13637與突變株SmMopB 在生理及病理學上之一些特性。結果發現,於穿透式和掃瞄式電子顯微鏡觀測下,突變株菌體的細胞外膜與肽聚醣層(peptidoglycan layer)之間有明顯分離現象,且菌體表面粗糙,細胞之間出現較多不明的細絲狀 (filament-like)物質。但在抗生素敏感性測試 (antibiotic susceptibility test),細胞毒性分析(lactate dehydrogenase released assay ),及組織病理學研究方面,突變株與野生株之間並無明顯差異。為進一步探討MopB蛋白在菌體與動物細胞作用上之影響,本研究利用小鼠皮膚 L929 細胞株 (mouse skin L929 fibroblast tissue),進行細菌貼附測試 (adhesion assay) 與吞噬測試 (phagocytosis assay),評估菌株的內化作用 (internalization)。研究指出經較長時間共培養後,SmMopB 附著於L929的能力增加,且被吞噬進入細胞的數目較多。本研究證實MopB 在維持 S. maltophilia細胞外膜結構穩定性上扮演重要角色。雖然突變株與野生株之細胞毒性無顯著差異,MopB蛋白缺失卻可能直接或間接促進細菌與細胞的黏附作用,並增加細菌被吞噬進入宿主細胞,相關機制則尚待探討。

Widespread in the environment Stenotrophomonas maltophilia (S. maltophilia) is a motile, nonfermentative, Gram-negative bacillus which was rarely reported to cause direct infection to human before. However, reports of nosocomial infection by this bacterium have increased rapidly in the last decade, especially on cancer patients, immunosuppression, and prolonged antibiotic therapies. Outer membrane proteins (Omps) play important roles in maintaining the structural integrity of outer membrane of bacteria, and function as adhesins, transporters, important components of antimicrobial resistance, and virulence related proteins. MopB protein is an abundant Omp in S. maltophilia ATCC13637, and the mopB mutant strain, SmMopB, has been constructed. In this study, SmMopB was used to analyze the physiological and pathological role of MopB protein in S. maltophilia, especially the effects on the infected cells and animals. Based on the morphology examination under Electron Microscopes (Transmission and Scanning), we observed that the outer membrane was not closely associated with the peptidoglycan layer and the outer surface became rough in SmMopB, and some obvious filaments were found among cells. On the other hand, the cytotoxicity of SmMopB strain seemed to have no significant differences from that of the wild type strain according to the results of histopathological study, assay of LDH released and antibiotic susceptibility test. However, the increasing adherence ability of SmMopB which might improve the internalization of bacteria into animal cells had been noticed along with longer incubation with L929 cells. Thus, MopB protein is demonstrated to be an important structural protein that stabilized the outer membrane of S. maltophilia. Although the cytotoxicity of SmMopB was not significantly changed, the increasing internalization and adhesion ability of these bacteria into L929 cells could be directly or indirectly related to the deficiency of MopB protein.
URI: http://hdl.handle.net/11455/23497
其他識別: U0005-1808201011132300
Appears in Collections:生命科學系所

Show full item record
 

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.